BST2 Antibody (120G8.04) - Azide and BSA Free

Flow Cytometry: BST2 Antibody (120G8.04) [DDX0390P-100]

Flow Cytometry: BST2 Antibody (120G8.04) [DDX0390P-100] - Facs sorting of mouse PDCs (120G8/CD11c)

Immunohistochemistry: BST2 Antibody (120G8.04) - Azide and BSA Free [DDX0390P-100] -

Treatment with HP06T07 induces accumulation of T cells, NK cells, and pDCs. Three mg/kg HP06T07 or PBS was intratumorally injected into right sides of tumors at 50 μl and was administered consecutively six times at 3-day intervals (day 10, 13, 16, 19, 22, and 25; I3). Two days after last treatment, tumors on the right sides of mice were harvested, embedded with paraffin, and stained with anti-mouse CD3ϵ (A), NK cell marker NCR1 (B), pDCs marker PDCA-1 (C), and CD19 (D). Positive cells were detected with alkaline phosphatase-conjugated goat anti-rat/rabbit IgG according to the manufacturer’s instructions. Representative images from one of three HP06T07- or PBS-treated mice are shown. Arrows indicate infiltration of immune cells. Original magnification, 200× and 400×. Histogram results were expressed as mean +/- SEM of positive cells/field evaluated at 400× images (n = 4–6/group). Statistical significance of differences was determined (*P < 0.05 and ***P < 0.001). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/32116691), licensed under a CC-BY license. Not internally tested by Novus Biologicals.